Connexin 32 Expression Reduces Malignant Phenotype in Human A549 Adenocarcinoma Cells: Implication of SRC Involvement

Oncology Reports - Greece
doi 10.3892/or.16.5.1149
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

The Involvement of Xanthohumol in the Expression of Annexin in Human Malignant Glioblastoma Cells

Open Biochemistry Journal
BiochemistryGeneticsMolecular Biology
2013English

Involvement of Notch1 Signaling in Malignant Progression of A549 Cells Subjected to Prolonged Cadmium Exposure

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2017English

Functional Expression and Characterization in Xenopus Laevis Oocytes of the ABCG2 Transporter Derived From A549 Human Lung Adenocarcinoma Cells

Oncology Reports
MedicineCancer ResearchOncology
2011English

Inhibition of SRC Activity Enhances the Tumor-Suppressive Effect of the Connexin 32 Gene in Caki-1 Renal Cancer Cells

Oncology Reports
MedicineCancer ResearchOncology
2006English

Analysis of eEF1Bγ Interactome in the Nuclear Fraction of A549 Human Lung Adenocarcinoma Cells

Biopolymers and Cell
BiochemistryGeneticsMolecular Biology
2019English

Role of Ceramide in Mediating the Inhibition of Telomerase Activity in A549 Human Lung Adenocarcinoma Cells

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2001English

Connexin 43 Recruits E-Cadherin Expression and Inhibits the Malignant Behaviour of Lung Cancer Cells.

Folia Histochemica et Cytobiologica
MedicineForensic MedicinePathologyHistology
2008English

BCL-xL Silencing Induces Alterations in Hsa-miR-608 Expression and Subsequent Cell Death in A549 and SK-LU1 Human Lung Adenocarcinoma Cells

PLoS ONE
Multidisciplinary
2013English

Anti-Tumor Activity of CrTX in Human Lung Adenocarcinoma Cell Line A549

Acta Pharmacologica Sinica
MedicinePharmacology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy